Amylyx’s ALS Drug Relyvrio Fails In PHOENIX Confirmatory Study, Setting Up Withdrawal Question

 
• By Sue Sutter
  
Light bulbs
The failed PHOENIX study was the confirmatory trial for Relyvrio, which was approved based on the smaller, successful CENTAUR study. • Source: Shutterstock

More from Clinical Trials

More from R&D